Geneva Capital Management LLC Idexx Laboratories Inc Transaction History

Geneva Capital Management LLC

$5.88 Billion
Q3 2024

A detailed history of Geneva Capital Management LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Geneva Capital Management LLC holds 49,220 shares of IDXX stock, worth $21.4 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

49,220

Previous 50,368 2.28%

Holding current value

$21.4 Million

Previous $24.5 Million 1.3%

% of portfolio

0.42%

Previous 0.45%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$455.08 - $517.19 $522,431 - $593,734	-1,148 Reduced 2.28%	49,220 $24.9 Million
Q2 2024 Aug 14, 2024	BUY	$468.04 - $548.53 $23.6 Million - $27.6 Million	50,368 New	50,368 $24.5 Million
Q1 2024 May 03, 2024	SELL	$515.08 - $576.87 $564,012 - $631,672	-1,095 Reduced 1.96%	54,747 $29.6 Million
Q4 2023 Feb 06, 2024	SELL	$391.37 - $557.56 $778,434 - $1.11 Million	-1,989 Reduced 3.44%	55,842 $31 Million
Q3 2023 Nov 13, 2023	SELL	$432.42 - $556.67 $879,542 - $1.13 Million	-2,034 Reduced 3.4%	57,831 $25.3 Million
Q2 2023 Aug 01, 2023	SELL	$450.7 - $503.61 $1.82 Million - $2.04 Million	-4,041 Reduced 6.32%	59,865 $30.1 Million
Q1 2023 May 12, 2023	SELL	$406.01 - $514.59 $336,988 - $427,109	-830 Reduced 1.28%	63,906 $32 Million
Q4 2022 Feb 07, 2023	SELL	$324.64 - $441.27 $1.69 Million - $2.3 Million	-5,201 Reduced 7.44%	64,736 $26.4 Million
Q3 2022 Nov 02, 2022	BUY	$325.8 - $407.78 $22.8 Million - $28.5 Million	69,937 New	69,937 $22.8 Million
Q2 2022 Aug 02, 2022	SELL	$327.37 - $553.44 $394,808 - $667,448	-1,206 Reduced 1.66%	71,598 $25.1 Million
Q1 2022 May 02, 2022	SELL	$466.52 - $631.01 $1.76 Million - $2.38 Million	-3,778 Reduced 4.93%	72,804 $39.8 Million
Q4 2021 Feb 02, 2022	SELL	$586.54 - $666.48 $1.58 Million - $1.8 Million	-2,698 Reduced 3.4%	76,582 $50.4 Million
Q3 2021 Nov 08, 2021	SELL	$621.9 - $705.76 $2.84 Million - $3.23 Million	-4,572 Reduced 5.45%	79,280 $49.3 Million
Q2 2021 Aug 11, 2021	SELL	$486.36 - $637.08 $2.05 Million - $2.68 Million	-4,207 Reduced 4.78%	83,852 $53 Million
Q1 2021 May 03, 2021	SELL	$465.18 - $551.79 $7.14 Million - $8.47 Million	-15,345 Reduced 14.84%	88,059 $43.1 Million
Q4 2020 Feb 02, 2021	SELL	$383.85 - $499.87 $11.9 Million - $15.5 Million	-30,910 Reduced 23.01%	103,404 $51.7 Million
Q3 2020 Nov 12, 2020	SELL	$334.54 - $406.31 $2.71 Million - $3.3 Million	-8,112 Reduced 5.7%	134,314 $52.8 Million
Q2 2020 Aug 13, 2020	SELL	$230.66 - $330.16 $680,677 - $974,302	-2,951 Reduced 2.03%	142,426 $47 Million
Q1 2020 May 15, 2020	BUY	$182.94 - $290.97 $26.6 Million - $42.3 Million	145,377 New	145,377 $35.2 Million

Others Institutions Holding IDXX

# of Institutions

1,191

Shares Held

72.6M

Call Options Held

167K

Put Options Held

343K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $36.2B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneva Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geneva Capital Management LLC with notifications on news.

Account

Geneva Capital Management LLC Idexx Laboratories Inc Transaction History